Advancing Cell Therapies with the Highest Quality Starting Material
The quality and consistency of the primary source material is directly related to the quality and efficacy of the final cell-based product. HemaCare is the global leader in providing human-derived biological products and apheresis collection services, directly enabling customers to advance autologous and allogeneic cell therapies. With 40 years of experience,
HemaCare has performed over 250,000 apheresis collections, developed the largest registry of healthy, repeat donors, and adopted the most stringent quality standards in the industry to provide customers with the highest quality primary cells available today. Cells are delivered with exceptional purity, viability, and cell quantity to ensure consistency and reproducibility. Additionally, our extensive custom services and product offering enable us to reliably meet customer specifications.